Explainer: Making a new generation of ‘guided-missile’ cancer drugs work
FRANKFURT (Reuters) – A class of treatments known as antibody-drug conjugates (ADC) combine cancer-tracking proteins with powerful cell toxins. The…
Drug developers take fresh aim at ‘guided-missile’ cancer drugs
FRANKFURT/ZURICH (Reuters) – Dozens of drugmakers are conducting human trials for a record 89 therapies that pair antibodies with toxic…